Skip to content
PeptideAgent

Telehealth providers in Ohio

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Ohio, including asynchronous care. What Ohio requires of telehealth prescribers and pharmacies, plus verified listings.

Ohio at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Ohio

No verified telehealth providers serving Ohio are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Ohio

ORC 4743.09 (enacted by House Bill 122 of the 134th General Assembly, effective March 23, 2022) lets licensed health care professionals provide telehealth services, including initial and annual visits, using synchronous or asynchronous technology when the standard of care for an in-person visit is satisfied. The State Medical Board's rule OAC 4731-37-01 applies this to physicians and physician assistants, holds telehealth to the in-person standard of care, permits synchronous or asynchronous communication technology if that standard can be met for the patient's condition, and allows non-controlled prescription drugs to be prescribed through telehealth under the rule's requirements. The prescriber must hold an Ohio license. None of the peptides in this database are controlled substances. [2] [3]

Compounded GLP-1 access in Ohio

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025, and the Ohio Board of Pharmacy's July 2025 GLP-1 FAQs reinforce that copies of the approved products are not routinely compoundable in Ohio. Ohio's asynchronous telehealth rule makes app-based prescribing lawful, so the main constraint for Ohio patients is the pharmacy side. [3] [4] [9]

Research use only sellers in Ohio

ORC chapter 4729 restricts the sale and distribution of dangerous drugs to licensed pharmacies, distributors, and prescribers, and the Board reminds licensees to verify that sellers are licensed. Board guidance for prescriber clinics and medical spas (updated December 8, 2025) says any drug labeled for research purposes only is unlawful for a clinic or med spa to possess, even with patient consent, and must be disposed of immediately, with patients advised to stop using it. [1] [5] [10] [11]

How to check a telehealth provider in Ohio

  1. Confirm the prescriber is licensed or registered to treat patients located in Ohio; the telehealth rules above explain what Ohio requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the State of Ohio Board of Pharmacy license lookup. [1] [4] [5] [6] [7] [8] [12]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Ohio. [1] [5] [10] [11]

Common questions in Ohio

Can I get a GLP-1 prescription in Ohio through an asynchronous telehealth app?

Yes, if the prescriber holds an Ohio license and the in-person standard of care can be met. ORC 4743.09 and OAC 4731-37-01 allow synchronous or asynchronous technology, including for initial visits, and non-controlled drugs like semaglutide may be prescribed through telehealth. [2] [3]

All peptide legal questions for Ohio

Sources

  1. [1]State of Ohio Board of Pharmacy
  2. [2]Ohio Revised Code 4743.09, Telehealth services
  3. [3]Ohio Administrative Code 4731-37-01, Telehealth (State Medical Board of Ohio)
  4. [4]State of Ohio Board of Pharmacy: Compounding of GLP-1 drug products in Ohio, guidance and FAQs (issued July 17, 2025)
  5. [5]Ohio Revised Code chapter 4729, Pharmacists; dangerous drugs
  6. [6]Ohio Revised Code 4729.54, Terminal distributor licenses
  7. [7]Ohio Administrative Code 4729:5-8-02, Non-resident pharmacies: licensure
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts
  11. [11]Ohio Board of Pharmacy: Ten Common Prescriber Clinic and Medical Spa Violations (updated 12/8/2025)
  12. [12]Ohio Board of Pharmacy: Responsible Person Requirements for Licensure (updated 9/10/2026)